TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
ADCT

ADC Therapeutics SA

Healthcare · Biotechnology

1.30$ -1.6% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow ADCT
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – – –
– +117.0% +122.4% +32.9% +20.2% -11.5% +40.3% +0.3% -42.7%
– -52.1% +138.2% +3,264.8% +60.9% -18.4% -72.6% -51.3% +5.1%
– -118.6% – +6,548.5% -77.4% +247.5% – – –
– -96.4% -1,738.9% – -227.1% – – -91.4% -762.7%
– -21.7% -13.0% +30.8% +127.0% -91.0% +457.4% -73.0% -69.6%
– -22.8% -10.3% +25.8% +136.0% -62.4% +28.2% -73.0% –
– -100.0% +487.5% -100.0% – – – – –
– +0.0% +0.0% – -21.3% -113.4% -100.0% – –
– -100.0% – +392.4% -46.0% -100.2% – +31.4% +55.5%
– -204.1% – – -91.5% -611.5% – – –
– – – – – – – – –

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?